fluorescein-5-isothiocyanate has been researched along with Antibody Deficiency Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mel'nikova, EV; Shurlygina, AV; Trufakin, VA | 1 |
| Budikhina, A; Pinegin, B | 1 |
| Carbone, DP; Gabrilovich, DI; Ishida, T; Oyama, T | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Chronodependent effect of interleukin-2 on mouse spleen cells in the model of cyclophosphamide immunosuppression.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Cell Proliferation; Cyclophosphamide; Fluorescein-5-isothiocyanate; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Interleukin-2; Male; Mice; Mice, Inbred CBA; Spleen; Statistics, Nonparametric; Time Factors | 2015 |
Evaluation of bactericidal activity of human biological fluids by flow cytofluorimetry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood; Cell Separation; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Immune System; Immunologic Deficiency Syndromes; Middle Aged; Multiple Myeloma; Staphylococcus aureus; Time Factors | 2007 |
Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors.
Topics: Animals; Antibodies, Monoclonal; Antigen Presentation; Antigens, Neoplasm; Bone Marrow; Cell Count; Cell Movement; Chemotactic Factors; Dendritic Cells; Endothelial Growth Factors; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Hematopoiesis; Immunization, Passive; Immunologic Deficiency Syndromes; Langerhans Cells; Lymph Nodes; Lymphokines; Mice; Mice, Inbred A; Mice, Inbred BALB C; Neoplasm Transplantation; Radiation Chimera; Sarcoma, Experimental; Skin; Specific Pathogen-Free Organisms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |